Chromium distribution in an oropharyngeal aspiration model for hexavalent chromium in rats

Sandra S. Wise,Haiyan Lu,Rachel M. Speer,John Pierce Wise,Jamie Young,Jennifer H. Toyoda,Idoia Meaza,Tayler J. Croom-Perez,J. Calvin Kouokam,Aaron Specht,Ke Jian Liu,Gary W. Hoyle

DOI: https://doi.org/10.1016/j.taap.2022.116294

IF: 4.46

2022-12-15

Toxicology and Applied Pharmacology

Abstract:Hexavalent chromium [Cr(VI)] is a well-known and widespread environmental contaminant associated with a variety of adverse health effects, in particular lung cancer. The primary route of exposure in humans is through inhalation. Particulate forms of Cr(VI) are the most potent but in vivo studies are difficult. Intratracheal instillation requires highly trained surgical procedures which also limits the number of repeated exposures possible and thus requires high doses. Inhalation studies can deliver lower more chronic doses but are expensive and generate dangerous aerosols. We evaluated an oropharyngeal aspiration exposure route for zinc chromate particles in Wistar rats. Animals were treated once per week for 90 days. We found chromium accumulated in the lungs, blood, and reproductive tissues of all treated animals. Additionally, we found inflammatory indicators in the lung were elevated and circulating lymphocytes had increased chromosomal damage. These results show oropharyngeal aspiration provides a practicable exposure route for chronic and sub-chronic exposures of Cr(VI) particles.

pharmacology & pharmacy,toxicology